Menten AI
Menten AI is a biotechnology company pioneering generative AI for peptide drug design. Its MAUD 1.0 platform designs peptide macrocycles de novo for complex, previously undruggable targets by combining generative AI with physics-based models and quantum simulations, reporting nanomolar potency, oral bioavailability, cell permeability, and a greater-than-90% hit rate. The company operates through enterprise partnerships with pharmaceutical organizations rather than a public developer platform, and at the time of this profile publishes no public API, SDK, or developer documentation. Surfaced as a portfolio company of Uncork Capital and added to the API Evangelist network.
Menten AI is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Drug Discovery, Generative AI, and Peptides.
Menten AI’s developer surface includes engineering blog and 5 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API
Other 1
Properties that don't map to a standard resource type